Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
With
National Institutes of Health (NIH)
To determine safety and toxicity of a regimen of high dose chemotherapy with allogeneic peripheral blood progenitor cell transplantation; determine the efficacy of the procedure by following clinical outcomes and quality of life measures; and evaluate graft versus host disease incidence and severity with regimen.
Age
18–61
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age: \>18 and \<61 years of age
You may not be if
Serum creatinine of \> 2 mg/dl or creatinine clearance \< 60 ml/min
